33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
71.92%
Net income growth above 1.5x MDB's 8.47%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
8.71%
D&A growth well above MDB's 5.00%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-100.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-80.59%
Negative yoy SBC while MDB is 13.32%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-13.93%
Both reduce yoy usage, with MDB at -115.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
79.50%
AR growth is negative or stable vs. MDB's 286.81%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
17.04%
Inventory growth of 17.04% while MDB is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-129.69%
Negative yoy AP while MDB is 5284.21%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
87.52%
Some yoy usage while MDB is negative at -188.61%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
679.61%
Some yoy increase while MDB is negative at -57.01%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-0.99%
Both yoy CFO lines are negative, with MDB at -48.12%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-13.49%
Negative yoy CapEx while MDB is 28.63%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth of 100.00% while MDB is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-12.29%
We reduce yoy invests while MDB stands at 90.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-15.31%
We cut debt repayment yoy while MDB is 69.06%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-99.97%
Negative yoy issuance while MDB is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.